AstraZeneca Pharma India Limited's market cap is currently ₹171.72B. The company's EPS TTM is ₹38.786; its P/E ratio is 177.09; and it has a dividend yield of 0.35%. AstraZeneca Pharma India Limited is scheduled to report earnings on February 14, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	₹ 12.96B	₹ 10.03B	₹ 8.06B	₹ 8.09B	₹ 8.32B
Gross Profit	₹ 6.22B	₹ 5.45B	₹ 4.48B	₹ 4.78B	₹ 4.97B
Operating Income	₹ 4.47B	₹ 945.09M	₹ 814.60M	₹ 1.26B	₹ 1.15B
EBITDA	₹ 2.36B	₹ 1.51B	₹ 1.01B	₹ 1.48B	₹ 1.34B
Net Income	₹ 1.62B	₹ 992.90M	₹ 616.00M	₹ 933.00M	₹ 722.10M
Balance Sheet
Cash & Short-Term Investments	₹ 5.06B	₹ 5.11B	₹ 4.48B	₹ 3.52B	₹ 2.52B
Total Assets	₹ 10.78B	₹ 9.85B	₹ 8.57B	₹ 7.75B	₹ 7.06B
Total Debt	₹ 45.90M	₹ 72.14M	₹ 86.30M	₹ 121.40M	₹ 118.40M
Net Debt	₹ -5.01B	₹ -4.93B	₹ -4.40B	₹ -3.40B	₹ -716.60M
Total Liabilities	₹ 3.66B	₹ 3.96B	₹ 3.45B	₹ 3.19B	₹ 3.42B
Stockholders' Equity	₹ 7.12B	₹ 5.89B	₹ 5.11B	₹ 4.56B	₹ 3.64B
Cash Flow
Free Cash Flow	₹ 171.10M	₹ 497.78M	₹ 911.80M	₹ 970.70M	₹ 732.00M
Operating Cash Flow	₹ 278.70M	₹ 582.98M	₹ 1.01B	₹ 1.05B	₹ 874.20M
Investing Cash Flow	₹ 217.40M	₹ 181.06M	₹ 47.40M	₹ 1.73B	₹ -1.71B
Financing Cash Flow	₹ -443.80M	₹ -244.84M	₹ -94.60M	₹ -89.70M	₹ -63.60M

Currency in INR

AstraZeneca Pharma India Limited Earnings and Revenue History

Income Statement >

AstraZeneca Pharma India Limited Debt to Assets

Balance Sheet >

AstraZeneca Pharma India Limited Cash Flow

Cash Flow >

AstraZeneca Pharma India Limited Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing